The future of medicine depends, in
large part, on the ability to pinpoint, study and treat disease with
increasing precision. At Coretech Holdings, we are creating tools
that make that possible. One of the large focuses of Coretech Holdings
today is the diagnosis of cancer through the use of innovative and patented
histotechnology tools. A new series of products are being developed
to meet the needs of cancer diagnosis in the "molecular age" in histopathology.
TOOLS FOR BETTER MEDICINE™
• Business
Overview
• Business
Model
• Core
Values
• Products
& Services
• History
Business Overview
--
The innovative, market-leading instrumentation we develop and manufacture
aids both life sciences and biotechnology research and clinical applications.
In all, we market more than 900 highly specialized products to medical
researchers and clinicians throughout the world.
Our company operates four business units, including:
- The Vibratome Company, a manufacturer of histology equipment
such as tissue sectioning microtomes used in laboratory research
and clinical diagnosis.
- Med-Core, Inc., developers of equipment for the clinical neuroscience
market. These tools are expected to improve outcomes on both stem
cell research and the treatment of Parkinson's disease, Huntington
disease and other neurological ailments.
- myNeuroLab.com, which produces BENCHmark stereotaxic instruments
used in research on small animals. The division markets these
and other proprietary neuroscience equipment on the myNeuroLab.com
website.
- The GlasswoRx Company, which manufactures precision tools used
in the production of glass microinstruments.
- McCormick Scientific is focused on developing the tissue processing
tools and methods for the new "molecular age" of histopathology.
With a strong portfolio of brand names and patents, the company
is uniquely positioned to be a strong player in the histology
field.
|
Home
: Contact : Policies
